Skip to main content
An official website of the United States government
Grant Details

Grant Number: 5UM1CA221940-03 Interpret this number
Primary Investigator: Tiro, Jasmin
Organization: Ut Southwestern Medical Center
Project Title: Multi-Level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
Fiscal Year: 2020


Abstract

ABSTRACT For more than 5 decades, the US has sought to lower cervical cancer deaths through screening; however, disparities remain. Introduction of oncogenic human papillomavirus (HPV)-based tests and HPV vaccines have expanded cervical cancer prevention strategies and changed screening and management guidelines. As technology, guidelines, and policies change, our MultilEvel OpTimization of the CeRvIcal Cancer Screening Process in Diverse Settings & Populations (METRICS) PROSPR II Research Center will elucidate multilevel factors that hamper or facilitate the cervical cancer screening process and reduce disparities in vulnerable populations. METRICS unites three PROSPR I Research Centers with demonstrated capability to provide validated data for a combined cohort of ~1.2 million screened and unscreened women. Our community settings represent 3 care delivery models—safety-net system, managed care system, and primary care provider networks in Texas, Washington, and Massachusetts. We will collect, harmonize, and document > 10 years of high-quality, comprehensive cervical cancer screening process data at the patient, provider, clinic, and system levels using a rich array of electronic clinical information systems and novel data sources. Our combined cohort is socioeconomically and geographically diverse and includes vulnerable groups such as HIV-infected and uninsured women. Our three interconnected observational projects are designed to understand how cervical cancer screening is delivered across our spectrum of delivery models, and how to optimize the screening process to reduce disparities. Innovative geospatial and Bayesian statistical methods in Project 1 will better elucidate at what levels variation in screening process occurs. Project 2 will investigate how multilevel programs and policies influence adherence to guidelines for average-risk women. Project 3 will inform precision screening for women with altered risk. Based on our observational findings, in years 4-5, we will design and implement pilot interventions leveraging IT-enabled tools to address key failures in the screening process and reduce disparities. Our transdisciplinary team has epidemiologists, primary and specialty care physicians, and intervention, implementation, and healthcare delivery experts. We are poised to efficiently evaluate the full cervical cancer screening process and provide expertise, leadership, and resources for cross-organ PROSPR II collaborations. Our cores and research projects will achieve our goals of advancing understanding of screening as practiced in community settings through: (1) analysis of multilevel observational data from our heterogeneous settings with diverse populations, (2) development and testing of impactful interventions to optimize the screening process, and (3) application of our novel observational projects and quality metrics to the cancer screening processes for other organs. Based on our successful experience leading and collaborating in PROSPR I, we thoughtfully organized our four cores to be able to launch research activities and contribute to trans-PROSPR II activities quickly and effectively.



Publications

Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019.
Authors: Sheridan L. , Pocobelli G. , Anderson M. , Li C.I. , Kruse G.R. , Tiro J.A. , Kamineni A. .
Source: Cancer Causes & Control : Ccc, 2024-11-13 00:00:00.0; , .
EPub date: 2024-11-13 00:00:00.0.
PMID: 39537980
Related Citations

Historical Bias in Mortgage Lending, Redlining, and Implications for the Uncertain Geographic Context Problem: A Study of Structural Housing Discrimination in Dallas and Boston.
Authors: Beauchamp A.M. , Tiro J.A. , Haas J.S. , Kobrin S.C. , Alegria M. , Hughes A.E. .
Source: Journal Of Urban Health : Bulletin Of The New York Academy Of Medicine, 2024-08-21 00:00:00.0; , .
EPub date: 2024-08-21 00:00:00.0.
PMID: 39168963
Related Citations

Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
Authors: Issaka R.B. , Ibekwe L.N. , Todd K.W. , Burnett-Hartman A.N. , Clark C.R. , Del Vecchio N.J. , Kamineni A. , Neslund-Dudas C. , Chubak J. , Corley D.A. , et al. .
Source: Cancer, 2024-08-09 00:00:00.0; , .
EPub date: 2024-08-09 00:00:00.0.
PMID: 39119731
Related Citations

Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results.
Authors: Dang T.H. , Rieu-Werden M.L. , Kobrin S.C. , Tiro J.A. , Werner C. , Lykken J.M. , Chubak J. , Atlas S.J. , Higashi R.T. , Lee S.C. , et al. .
Source: Journal Of General Internal Medicine, 2024-07-25 00:00:00.0; , .
EPub date: 2024-07-25 00:00:00.0.
PMID: 39060782
Related Citations

Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study.
Authors: Herbach E.L. , Curran M. , Roberson M.L. , Carnahan R.M. , McDowell B.D. , Wang K. , Lizarraga I. , Nash S.H. , Charlton M. .
Source: Cancer Causes & Control : Ccc, 2024 Jul; 35(7), p. 1017-1031.
EPub date: 2024-03-28 00:00:00.0.
PMID: 38546924
Related Citations

Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.
Authors: Cheng D. , Rieu-Werden M.L. , Lykken J.M. , Werner C.L. , Feldman S. , Silver M.I. , Atlas S.J. , Tiro J.A. , Haas J.S. , Kamineni A. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2024-07-01 00:00:00.0; 33(7), p. 912-922.
PMID: 38652505
Related Citations

Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study.
Authors: Hahn E.E. , Munoz-Plaza C.E. , Jensen C.D. , Ghai N.R. , Pak K. , Amundsen B.I. , Contreras R. , Cannizzaro N. , Chubak J. , Green B.B. , et al. .
Source: Journal Of General Internal Medicine, 2024-05-21 00:00:00.0; , .
EPub date: 2024-05-21 00:00:00.0.
PMID: 38771535
Related Citations

Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix.
Authors: McDowell A. , Rieu-Werden M.L. , Atlas S.J. , Fields C.D. , Goldstein R.H. , Gundersen G.D. , Haas J.S. , Higashi R.T. , Pruitt S.L. , Silver M.I. , et al. .
Source: Lgbt Health, 2024-04-22 00:00:00.0; , .
EPub date: 2024-04-22 00:00:00.0.
PMID: 38648535
Related Citations

Validation of human immunodeficiency virus diagnosis codes among women enrollees of a U.S. health plan.
Authors: Pocobelli G. , Oliver M. , Albertson-Junkans L. , Gundersen G. , Kamineni A. .
Source: Bmc Health Services Research, 2024-02-22 00:00:00.0; 24(1), p. 234.
EPub date: 2024-02-22 00:00:00.0.
PMID: 38389066
Related Citations

Data gaps and opportunities for modeling cancer health equity.
Authors: Trentham-Dietz A. , Corley D.A. , Del Vecchio N.J. , Greenlee R.T. , Haas J.S. , Hubbard R.A. , Hughes A.E. , Kim J.J. , Kobrin S. , Li C.I. , et al. .
Source: Journal Of The National Cancer Institute. Monographs, 2023-11-08 00:00:00.0; 2023(62), p. 246-254.
PMID: 37947335
Related Citations

Disparities in Gynecologic Cancers.
Authors: Lee N.K. , Tiro J.A. , Odunsi K. .
Source: Cancer Journal (sudbury, Mass.), 2023 Nov-Dec 01; 29(6), p. 343-353.
PMID: 37963369
Related Citations

Racial and Ethnic Disparities in Cervical Cancer Screening From Three U.S. Healthcare Settings.
Authors: Spencer J.C. , Kim J.J. , Tiro J.A. , Feldman S.J. , Kobrin S.C. , Skinner C.S. , Wang L. , McCarthy A.M. , Atlas S.J. , Pruitt S.L. , et al. .
Source: American Journal Of Preventive Medicine, 2023 Oct; 65(4), p. 667-677.
EPub date: 2023-05-03 00:00:00.0.
PMID: 37146839
Related Citations

Timing of Colposcopy and Risk of Cervical Cancer.
Authors: Alimena S. , Lykken J.M. , Tiro J.A. , Chubak J. , Kamineni A. , Haas J.S. , Werner C. , Kobrin S.C. , Feldman S. .
Source: Obstetrics And Gynecology, 2023-08-22 00:00:00.0; , .
EPub date: 2023-08-22 00:00:00.0.
PMID: 37607530
Related Citations

Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systems.
Authors: Kruse G.R. , Lykken J.M. , Kim E.J. , Haas J.S. , Higashi R.T. , Atlas S.J. , McCarthy A.M. , Tiro J.A. , Silver M.I. , Skinner C.S. , et al. .
Source: Jnci Cancer Spectrum, 2023-01-03 00:00:00.0; 7(1), .
PMID: 36469348
Related Citations

Factors associated with timely colposcopy following an abnormal cervical cancer test result.
Authors: Feldman S. , Lykken J.M. , Haas J.S. , Werner C.L. , Kobrin S.C. , Tiro J.A. , Chubak J. , Kamineni A. .
Source: Preventive Medicine, 2022 Nov; 164, p. 107307.
EPub date: 2022-10-18 00:00:00.0.
PMID: 36270434
Related Citations

Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval.
Authors: Chubak J. , Burnett-Hartman A.N. , Barlow W.E. , Corley D.A. , Croswell J.M. , Neslund-Dudas C. , Vachani A. , Silver M.I. , Tiro J.A. , Kamineni A. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2022-08-02 00:00:00.0; 31(8), p. 1517-1520.
PMID: 35916602
Related Citations

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
Authors: Beaber E.F. , Kamineni A. , Burnett-Hartman A.N. , Hixon B. , Kobrin S.C. , Li C.I. , Oliver M. , Rendle K.A. , Skinner C.S. , Todd K. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2022-08-02 00:00:00.0; 31(8), p. 1521-1531.
PMID: 35916603
Related Citations

Natural Language Processing to Identify Abnormal Breast, Lung, and Cervical Cancer Screening Test Results from Unstructured Reports to Support Timely Follow-up.
Authors: Diamond C.J. , Laurentiev J. , Yang J. , Wint A. , Harris K.A. , Dang T.H. , Mecker A. , Carpenter E.B. , Tosteson A.N. , Wright A. , et al. .
Source: Studies In Health Technology And Informatics, 2022-06-06 00:00:00.0; 290, p. 433-437.
PMID: 35673051
Related Citations

Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial.
Authors: Kapinos K.A. , Halm E.A. , Murphy C.C. , Santini N.O. , Loewen A.C. , Skinner C.S. , Singal A.G. .
Source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association, 2022-02-07 00:00:00.0; , .
EPub date: 2022-02-07 00:00:00.0.
PMID: 35144024
Related Citations

De-implementation of cervical cancer screening before age 21.
Authors: Silver M.I. , Anderson M.L. , Beaber E.F. , Haas J.S. , Kobrin S. , Pocobelli G. , Skinner C.S. , Tiro J.A. , Kamineni A. .
Source: Preventive Medicine, 2021 Dec; 153, p. 106815.
EPub date: 2021-09-29 00:00:00.0.
PMID: 34599920
Related Citations

Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics.
Authors: Haas J.S. , Cheng D. , Yu L. , Atlas S.J. , Clark C. , Feldman S. , Silver M.I. , Kamineni A. , Chubak J. , Pocobelli G. , et al. .
Source: Preventive Medicine, 2021-11-08 00:00:00.0; 154, p. 106871.
EPub date: 2021-11-08 00:00:00.0.
PMID: 34762966
Related Citations

The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.
Authors: Marcondes F.O. , Cheng D. , Warner E.T. , Kamran S.C. , Haas J.S. .
Source: Preventive Medicine, 2021 10; 151, p. 106640.
EPub date: 2021-06-30 00:00:00.0.
PMID: 34217419
Related Citations

Early assessment of the first wave of the COVID-19 pandemic on cancer screening services: The International Cancer Screening Network COVID-19 survey.
Authors: Puricelli Perin D.M. , Elfström K.M. , Bulliard J.L. , Burón A. , Campbell C. , Flugelman A.A. , Giordano L. , Kamineni A. , Ponti A. , Rabeneck L. , et al. .
Source: Preventive Medicine, 2021 10; 151, p. 106642.
EPub date: 2021-06-30 00:00:00.0.
PMID: 34217420
Related Citations

Exposure definition in case-control studies of cervical cancer screening: a systematic literature review.
Authors: Castanon A. , Kamineni A. , Elfstrøm K.M. , Lim A.W. , Sasieni P. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2021-09-14 00:00:00.0; , .
EPub date: 2021-09-14 00:00:00.0.
PMID: 34526301
Related Citations

How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention.
Authors: Feldman S. , Haas J.S. .
Source: Journal Of The National Cancer Institute, 2021-06-01 00:00:00.0; 113(6), p. 662-664.
PMID: 32609333
Related Citations

Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
Authors: Burger E.A. , Jansen E.E. , Killen J. , Kok I.M. , Smith M.A. , Sy S. , Dunnewind N. , G Campos N. , Haas J.S. , Kobrin S. , et al. .
Source: Journal Of Medical Screening, 2021-03-17 00:00:00.0; , p. 9691413211001097.
EPub date: 2021-03-17 00:00:00.0.
PMID: 33730899
Related Citations

Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
Authors: Balachandra S. , Kusin S.B. , Lee R. , Blackwell J.M. , Tiro J.A. , Cowell L.G. , Chiang C.M. , Wu S.Y. , Varma S. , Rivera E.L. , et al. .
Source: Cancer, 2021-03-15 00:00:00.0; 127(6), p. 850-864.
EPub date: 2020-12-03 00:00:00.0.
PMID: 33270909
Related Citations

Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV.
Authors: Rodriguez S.A. , Higashi R.T. , Betts A.C. , Ortiz C. , Tiro J.A. , Luque A.E. , Barnes A. .
Source: Journal Of Lower Genital Tract Disease, 2020-11-03 00:00:00.0; , .
EPub date: 2020-11-03 00:00:00.0.
PMID: 33149011
Related Citations

Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems.
Authors: Ghai N.R. , Jensen C.D. , Merchant S.A. , Schottinger J.E. , Lee J.K. , Chubak J. , Kamineni A. , Halm E.A. , Skinner C.S. , Haas J.S. , et al. .
Source: Cancer Prevention Research (philadelphia, Pa.), 2020-07-15 00:00:00.0; , .
EPub date: 2020-07-15 00:00:00.0.
PMID: 32669318
Related Citations

Pathways to breast cancer screening artificial intelligence algorithm validation.
Authors: Lee C.I. , Houssami N. , Elmore J.G. , Buist D.S.M. .
Source: Breast (edinburgh, Scotland), 2019-09-09 00:00:00.0; , .
EPub date: 2019-09-09 00:00:00.0.
PMID: 31540699
Related Citations

Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort.
Authors: Kamineni A. , Tiro J.A. , Beaber E.F. , Silverberg M.J. , Wheeler C.M. , Chao C.R. , Chubak J. , Skinner C.S. , Corley D.A. , Kim J.J. , et al. .
Source: International Journal Of Cancer, 2018-10-24 00:00:00.0; , .
EPub date: 2018-10-24 00:00:00.0.
PMID: 30353911
Related Citations

Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women.
Authors: Feldman S. , Cook E. , Davis M. , Gershman S.T. , Hanchate A. , Haas J.S. , Perkins R.B. .
Source: Journal Of Lower Genital Tract Disease, 2018 Oct; 22(4), p. 314-317.
PMID: 30256336
Related Citations

Cervical Cancer Burden and Opportunities for Prevention in a Safety-net Healthcare System.
Authors: Pruitt S.L. , Werner C.L. , Borton E.K. , Sanders J.M. , Balasubramanian B.A. , Barnes A. , Betts A.C. , Skinner C.S. , Tiro J.A. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2018-09-05 00:00:00.0; , .
EPub date: 2018-09-05 00:00:00.0.
PMID: 30185535
Related Citations



Back to Top